You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ATNM Award Disclosure
David Matthew T · SEC Form 4 · Filed Oct 16, 2026
Award
Calculated transaction value
$0
David Matthew T Chief Financial Officer
ATNM
Transaction date
Oct 14, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed 2 days later
ATNM daily price context
Close on/before transaction
$0.97
Oct 14, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to purchase) on Common Stock
- Quantity / price
- 250,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-110340
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. ATNM | Award | Oct 14, 2026 | $0 |
| Actinium Pharmaceuticals, Inc. ATNM Current | Award | Oct 14, 2026 | $0 |